Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Inclusion of Inclisiran Into Standard of Care in Patients With Recent Acute Coronary Syndrome
NCT07684469Phase 4Not yet recruiting
- Sponsor
- Novartis
- Start
- Oct 2026
- Primary completion
- Feb 2028
01
Overview
A Phase 4 trial of inclisiran in acute coronary syndrome (ACS), sponsored by Novartis. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
inclisiran
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT07684469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07684469.